Related Experiment Video
Updated: Apr 26, 2026
Long Term Intravital Multiphoton Microscopy Imaging of Immune Cells in Healthy and Diseased Liver Using CXCR6.Gfp Reporter Mice
Published on: March 24, 2015
A cell-type-specific role for murine Commd1 in liver inflammation
Paulina Bartuzi1, Tobias Wijshake1, Daphne C Dekker1
1University of Groningen, University Medical Center Groningen, Department of Pediatrics, Molecular Genetics Section, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
Copper Metabolism MURR1 Domain-containing 1 (COMMD1) suppresses NF-κB, a key factor in liver inflammation and NAFLD. COMMD1 deficiency in myeloid cells worsens liver inflammation and lipid accumulation, highlighting its crucial role in controlling NAFLD progression.
Area of Science:
- Cell biology
- Immunology
- Hepatology
Background:
- Nuclear factor-kappa B (NF-κB) is central to inflammatory responses and implicated in non-alcoholic fatty liver disease (NAFLD).
- Sustained NF-κB activation disrupts tissue homeostasis, necessitating precise termination mechanisms.
- Copper Metabolism MURR1 Domain-containing 1 (COMMD1) is known to inhibit NF-κB, but its role in liver inflammation remains unexplored.
Purpose of the Study:
- To investigate the cell-type-specific function of COMMD1 in regulating liver inflammation and non-alcoholic fatty liver disease (NAFLD).
- To elucidate the impact of COMMD1 deficiency in hepatocytes and myeloid cells on liver inflammatory responses and lipid metabolism.
Main Methods:
- Generation and analysis of hepatocyte-specific and myeloid-specific Commd1-deficient mouse models.
- Utilizing a high-fat, high-cholesterol (HFC) diet to induce non-alcoholic fatty liver disease (NAFLD) and associated liver inflammation.
- Assessment of NF-κB activation, inflammatory cytokine levels, and hepatic lipid accumulation in Commd1-deficient mice.
Main Results:
- Hepatocyte-specific Commd1 deficiency led to increased NF-κB p65 (RelA) levels without exacerbating liver inflammation.
- Myeloid-specific Commd1 deficiency significantly worsened diet-induced liver inflammation and hepatic lipid accumulation.
- Both hepatocyte and myeloid Commd1 deficiency augmented hepatic lipid accumulation, with increased steatosis in myeloid-deficient mice linked to elevated proinflammatory cytokines.
Conclusions:
- COMMD1 plays a cell-type-specific role in suppressing liver inflammation, particularly through its function in myeloid cells.
- COMMD1 deficiency contributes to the progression of non-alcoholic fatty liver disease (NAFLD) by modulating both inflammation and lipid accumulation.
- Targeting COMMD1 may offer a therapeutic strategy for managing liver inflammation and NAFLD.
